ARCHIVES

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

Prognostic Factors Don’t Explain Better Prostate Cancer Survival In Most Asian Men

August 31, 2007

Family History of BRCA Mutation Does Not Equal Increased Risk

October 28, 2011

ODAC Recommends Approval Of Nplate For Thrombocytopenia.

March 21, 2008

ImClone Protocol Generates More Questions Than Answers

March 8, 2002

Another Feasibility Study For Women’s Wealth Trial? Yes And No; It’s ‘Class Of 84’s” Adieu

December 14, 1990

Space Station Attacked By Health Research Advocates on Earth

May 8, 1992